Study the Effect of Dyslipidemia in Iraqi Diabetes Patients with Both Gender
Keywords:
Dyslipidemia, cardio vascular disease, T2DM, Gender.Abstract
The aim of this article to Study the Effect of Dyslipidemia in Iraqi Diabetic Patients with Both Gender. Twenty hindered participant (50) male with dyslipidemia compared with (50) male without dyslipidemia and (50) female with dyslipidemia compared with (50) female without dyslipidemia. There was a highly significant increase of TC,TG and LDL-c in Male with dyslipidemia when compared with Male without dyslipidemia, while a significant decreased of HDL-c in Male with dyslipidemia when compared with Male Control, and a highly significant incased of TC,TG and LDL-c in female with dyslipidemia when compared with female without dyslipidemia .while a significant decreased of HDL-c in female with dyslipidemia when compared with female without dyslipidemia. It can conclude increased TC, TG and LDL-C levels, while decreased level of HDL-C in male and female with dyslipidemia these due to Lipids are a major role in the development of CVD, and controlling these factors has become a top priority for health policymakers of both genders.
Downloads
References
T Kassahun Hailel ,. Abebe Timerga. Dyslipidemia and Its
Associated Risk Factors Among Adult Type-2 Diabetic
Patients at Jimma University Medical Center, Jimma,
Southwest Ethiopia. Diabetes, Metabolic Syndrome and
Obesity: Targets and Therapy 2020:13 4589-4597.
-Hirano T. Pathophysiology of diabetic dyslipidemia. J
Atheroscler Thromb. 2018;25(9):771-782.
Ambachew H, Shimelis T, Lemma K. Dyslipidemia among
diabetic patients in Southern Ethiopia. J Diabetes
Endocrinol. 2O15;6 (4):19-24. doi:10.5897/JDE2015.0086
-Daya R, Bayat Z, Raal FJ. Prevalence and pattern of
dyslipidemia in type 2 diabetes mellitus patients at a
tertiary care hospital. J Endocrinol Metab Diabetes.
;22(3):31-35. doi:10.1080/ 16089677.2017.1360064 10.
-Sugden M, Holness M. Pathophysiology of diabetic dyslipidemia: implications for atherogenesis and treatment. Clin Lipidol. 2011;6 (4):401-411.
doi:10.2217/clp.11.32 11.
-Wu L, Parhofer KG. Diabetic dyslipidemia. Metabolism.
;63 (12):1469-1479.
doi:10.1016/j.metabol.2014.08.010 12.
- Hirano T. Pathophysiology of diabetic dyslipidemia. J
Atheroscler Thromb. 2018;25(9):1-12.
doi:10.5551/jat.RV17023 13.
- Schofield JD, Liu Y, Rayaz PR, Malik RA, Soran H.
Diabetes dyslipidemia. Diabetes Ther. 2O16;7(2):2O3-
doi:10.1007/ s13300-016-0167-x 14.
-Goldberg IRAJ. Diabetic dyslipidemia: causes and
consequences. J Clin Endocrinol Metab. 2001;86(3):965-
doi:10.1210/jcem.86.3.7304 15.
- Salim A, Ghouth B, Ba-karman AA, Alaidroos HA, Alajely
MH. Prevalence and patterns of dyslipidemia among
type 2 diabetes mellitus patients in Mukalla City,
Yemen, in 2017. J Community Med Public Health.
;6:6-11.
Kiplagat SV, Lydia K, Jemimah K, Drusilla M. Prevalence
of dyslipidemia, and the associated factors among type
diabetes patients in Turbo Sub-county, Kenya. J
Endocrinol Diabetes. 2017;4(5):1-9. doi:10.15226/2374-
/4/5/00190.
- Ploypun Narindrarangkura , William Bosl , Ram Rangsin
and Panadda Hatthachote. Prevalence of dyslipidemia
associated with complications in diabetic patients: a
nationwide study in Thailand. Narindrarangkura et al.
Lipids in Health and Disease (2019) 18:90.1-9.
-Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W,
Hasani MR, Yusufali AH, et al; INTERHEART
Investigators in Middle East. Association of risk factors
with acute myocardial infarction in Middle Eastern
countries: the INTERHEART Middle East study. Eur J
Prev Cardiol 2014 Apr;21(4):400-410.
-Expert Dyslipidemia Panel of the International
Atherosclerosis Society Panel members. An
International Atherosclerosis Society Position Paper:
global recommendations for the management of
dyslipidemia-full report. J Clin Lipidol 2014 JanFeb;8(1):29-60.
- Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE,
Jones PH, et al. National Lipid Association
recommendations for patient-centered management of
dyslipidemia: part 1 - executive summary. J Clin Lipidol
Sep-Oct;8(5):473-488.
-Khalid Al-Rasadi and Hilal Al-Sabti. Dyslipidemia in the
Arabian Gulf and its Impact on Cardiovascular Risk
Outcome. Oman Medical Journal [2015], Vol. 30, No. 6:
-405. DOI 10.5001/omj.2015.81
-Simon C., Everitt H. & Kendrick T. Oxford Handbook of
General Practice. 2nd Edition. Oxford University Press.
Pp. 712-728 (2005).
-Richmond W. (1992). Analytical reviews in clinical
biochemistry: the quantitative analysis of cholesterol.
Ann. Clin.Biochem. 29(26):577-597.
Fossati .P and Prencipe L.(1982): Serum triglycerides
determined colorimetrically with an enzyme that
produces hydrogen peroxide. Clin.Chern. 28(10):2077-
- Lopes-Virella M., Ston P. and Ellis S. Cholesterol
dtermination in high density lipoprotein separated by
three different methods.Cline.Chern.,23(5):882-884
(1977).
-Friedewald, William T., Robert I., Levy & Donald S.,
Fredrickson Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of
the preparative ultracentrifuge. Clinical Chemistry,
(6):499-502 (1972).
-Helmut JR., and Yvette SL . A simple methods for the
determination of blood urea nitrogen with special
refrnces to automatic collorematric analysis.Clinical
Chemestry . 5(6).1959.
-Larsen ,K.CIin.Chim.Acta.41:204(1972).
-He Z, Liu Z, Liu M, Guo C, Xu R, Li F, et al. Efficacy of
endoscopic screening for esophageal cancer in China
(ESECC): design and preliminary results of a
population-based randomised controlled trial. Gut.
;68(2):198-206. 21.
-Chen W-W, Gao R-L, Liu L-S, Zhu M-L, Wang W, Wang
Y-J, et al. China cardiovascular diseases report 2015: a
summary. J Geriatr Cardiol. 2017;14(1):1-10. 22.
-Weiwei C, Runlin G, Lisheng L, Manlu Z, Wen W, Yongjun
W, et al. Outline of the report on cardiovascular
diseases in China, 2014. Eur Heart J Suppl. 2016;18:F2-
F11. 23.
-Boo S, Yoon YJ, Oh H. Evaluating the prevalence,
awareness, and control of hypertension, diabetes, and
dyslipidemia in Korea using the NHIS-NSC database: a
cross-sectional analysis. Medicine (Baltimore).
O18;97(51): e13713.
- Minmin Wang , Mengfei Liu , Fenglei Li , Chuanhai Guo ,
Zhen Liu , Yaqi Pan , Ying Liu , Fangfang Liu , Hong Cai ,
Yangfeng Wu , Zhonghu He and Yang Ke. Gender
heterogeneity in dyslipidemia prevalence, trends with
age and associated factors in middle age rural Chinese.
Lipids in Health and Disease (2020) 19:135.1-11.
- Waad-Allah S Mula-Abed. Prevalence of dyslipidemia in
the Iraqi adult population.saudi Medical
Journal 28(12):1868-74.
- Hokanson JE. Hypertriglyceridemia and risk of coronary
heart disease. Curr Cardiol Rep. 2002;4(6):488-93
- Ginsberg HN, Zhang YL, Hernandez-Ono A. Metabolic
syndrome: focus on dyslipidemia. Obesity.
;14(Suppl 1):41S-9S.
- Pont F, Duvillard L, Florentin E, Gambert P, Verges B.
Early kinetic abnormalities of apoB-containing
lipoproteins in insulin-resistant women with abdominal
obesity. Arterioscler Thromb Vase Biol.
OO2;22(1O):1726-32.
- Valeska Ormazaball , Soumyalekshmi Nair2 , Omar
Elfeky2 , Claudio Aguayo3 , Carlos Salomon2,3,4* and
Felipe A. Zuniga. Association between insulin resistance
and the development of cardiovascular disease.
Cardiovasc Diabetol (2018) 17:122.
- Yasser Taher Al-Hassan, Eduardo L. Fabella* , Edric
Estrella and Mohammad Aatif. Prevalence and
Determinants of Dyslipidemia: Data from a Saudi
University Clinic. The Open Public Health Journal, 2018,
417-425.
- Stone NJ. Secondary causes of hyperlipidemia.Med Clin
;78: 117e141. PMID: 8283927.
- Chait A, Brunzell JD. Acquired hyperlipidemia
(secondarydyslipoproteinemias).Endocrinol Metab Clin
N Am 1990; 19:259e278. PMID: 2192873.
- Aguilar-Salinas CA, Olaiz G, Valles V, Torres
JMR,Pe rez FJG, Rull JA, et al. High prevalence of low
HDLcholesterol concentrations and mixed
hyperlipidemia in aMexican nationwide survey.J Lipid
Res 2001; 42: 1298e1307.PMID:11483632.
-Brinton EA, Eisenberg S, Breslow JL. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreosingHDL apolipoprotein transport
rates.J Clin Invest 1990; 85:144. PMID: 2104877.
- Mohammed A. AI-DuaisYahya S. Al-Awthan. Prevalence
of dyslipidemia among students of a Yemeni University.
Journal of Taibah University Medical Sciences (2019)
(2), 163-171.
- Hend Soliman* and Amany Ibrahim. Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes. Soliman and Ibrahim Egyptian Pediatric Association Gazette (2021) 69:21
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
